ClearLight Closes Lab Services and Offers Expert Consulting Services Learn More

Virtual Immuno-Oncology 360º (Virtual)

IO360˚convened stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. ClearLight was a Quick Fire Sponsor. 

The event is finished.

Date

Feb 23 - 26 2021
Expired!

Time

8:00 am - 6:00 pm

Tags

3D Histopathology 3D IHC 3D IHC Services 3D Imaging AACR 2022 antibodies for 3D IHC antibody feasibility brain Cancer characterization CLARITY CLARITY compatibility clearing ClearLight ClearLight Bio Events Collaboration CRYSTAL Deisseroth Dr. Sharla White hydrogel imaging complex structure Immuno-oncology License light-sheet fluorescence microscopy Microenvironment Mouse Intestine Multiplex nature optimized antibodies Posters Presentations publication science podcast See More Biology SPED Stanford Transcriptional Analysis Tumor video women in STEM

Categories

Archives

Comments are closed.

Analysis can be performed for select biomarkers, please contact us to find out if your target of interest is one of them. Imaging is currently performed on select fields of view instead of the entire sample.

Submission Guidelines

Tissue Sample Requirements: